EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of New Anti‐ Trypanosoma brucei Leads: An Integrated CRK12 ‐Guided Virtual Screen With Experimental Validation

Qin Li, Chenggong Fu, Jiayi Luo iD, Qianqian Zhang iD, Lingling Wang, Xiaomeng Liu, Jiayue Qiu iD, Xiaoqing Gong, Henry H Y Tong iD, Xiaojun Yao iD, Dehua Lai iD, Huanxiang Liu iD

Chemical Biology & Drug Design · 2026

DOI: 10.1111/cbdd.70389 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2026. Verfasst von Qin Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Applied Sciences, Macao Polytechnic University, Macao SAR, China. Hauptthemen laut MEDLINE: Trypanosoma brucei brucei, Trypanocidal Agents, Protozoan Proteins, Protein Kinase Inhibitors. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Macao Science and Technology Development Fund, National Natural Science Foundation of China, Fundo para o Desenvolvimento das Ciências e da Tecnologia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human African trypanosomiasis (HAT), caused by Trypanosoma brucei , remains a neglected tropical disease with a critical shortage of therapeutic options, underscoring the need for new chemotypes. Cell division cycle‐2‐related kinase 12 (CRK12) has emerged as a genetically essential and chemically validated target in kinetoplastids, yet experimentally supported CRK12‐targeting chemotypes against T. brucei remain limited, and no experimental CRK12 structure is available. Here, we developed an integrated computational‐experimental screening workflow to accelerate CRK12‐guided hit discovery, combining ligand‐based prescreening, structure‐based virtual screening, molecular dynamics (MD) refinement, and experimental validation. An 8.6‐million‐compound library was prescreened using MACCS fingerprint screening and complex‐based pharmacophore screening, followed by staged docking and MD simulations to prioritize candidates for experimental testing. Notably, four of ten purchased compounds showed strong growth inhibition against T. brucei at 10 μM, with IC 50 values of 6.09, 1.47, 0.81, and 1.33 μM, demonstrating a promising hit rate for this data‐limited target. Binding‐mode analysis revealed a conserved hinge‐anchoring interaction pattern in the ATP‐binding pocket, providing a structural rationale for follow‐up analogue design. Overall, this study identifies new chemical starting points for anti‐ T. brucei drug discovery and demonstrates the utility of an AlphaFold2‐enabled CRK12‐guided screening strategy for targets with limited structural and ligand data.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trypanosoma brucei bruceiTrypanocidal AgentsProtozoan ProteinsProtein Kinase InhibitorsProto-Oncogene Proteins c-crkMolecular Dynamics SimulationMolecular Docking SimulationHumansPharmacophoreLigandsDrug Evaluation, PreclinicalTrypanosomiasis, AfricanBinding Sites

Stichwörter der Autor:innen

CRK12drug discoveryhuman African trypanosomiasis (HAT)molecular dockingneglected tropical diseasevirtual screening

Substanzen

Trypanocidal AgentsLigandsProtozoan ProteinsProtein Kinase InhibitorsProto-Oncogene Proteins c-crk

Autor:innen und Institutionen

  • Faculty of Applied Sciences, Macao Polytechnic University, Macao SAR, China.
  • MOE Key Laboratory of Gene Function and Regulation, State Key Laboratory of Biocontrol and Guangdong Provincial Key Laboratory of Aquatic Economic Animals, School of Life Sciences, Sun Yat-Sen University, Guangzhou, Chi…

ORCID-Profile: Jiayi Luo, Qianqian Zhang, Jiayue Qiu, Henry H Y Tong, Xiaojun Yao, Dehua Lai, Huanxiang Liu

Förderung

  • Macao Science and Technology Development Fund
  • National Natural Science Foundation of China
  • Fundo para o Desenvolvimento das Ciências e da Tecnologia

Zitieren

APA

Li, Q., Fu, C., Luo, J., Zhang, Q., Wang, L., Liu, X., Qiu, J., Gong, X., Tong, H. H. Y., Yao, X., Lai, D., & Liu, H. (2026). Identification of New Anti‐ Trypanosoma brucei Leads: An Integrated CRK12 ‐Guided Virtual Screen With Experimental Validation. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70389

Vancouver

Li Q, Fu C, Luo J, Zhang Q, Wang L, Liu X, et al. Identification of New Anti‐ Trypanosoma brucei Leads: An Integrated CRK12 ‐Guided Virtual Screen With Experimental Validation. Chemical Biology & Drug Design. 2026. doi:10.1111/cbdd.70389

BibTeX
@article{Li2026,
  author = {Li, Qin and Fu, Chenggong and Luo, Jiayi and Zhang, Qianqian and Wang, Lingling and Liu, Xiaomeng and Qiu, Jiayue and Gong, Xiaoqing and Tong, Henry H Y and Yao, Xiaojun and Lai, Dehua and Liu, Huanxiang},
  title = {Identification of New Anti‐ Trypanosoma brucei Leads: An Integrated CRK12 ‐Guided Virtual Screen With Experimental Validation},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  doi = {10.1111/cbdd.70389}
}
Kostenlos starten →